McKesson Corporation vs Eli Lilly & Co.
MCK vs LLY — side-by-side comparison from reported financials. MCK leads 3, LLY leads 8 of 11 comparable metrics.
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | MCK | LLY |
|---|---|---|
| Price | $938.84 | $1 177.20 |
| Market cap | $109B | $1.05T |
| Revenue (TTM) | $411B | $79.7B |
| Revenue growth | +13.4% | +31.7% |
| Net margin | 1.1% | 33.5% |
| Free cash flow | $6.42B | $18.2B |
| Net cash (debt) | ($4.81B) | ($35.2B) |
| 1-year price return | +23.9% | +37.6% |
| P/E | 23.8 | 41.6 |
| P/E vs own history (cheap-side %) | 59% | 88% |
| Dividend yield | 0.36% | 0.52% |
| Return on equity | 39% | 93% |
| Altman Z-score | 2.25 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 43,000 | 50,000 |
Full résumé-style profiles: MCK CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.